- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Active Pharmaceutical Ingredients (API) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Active Pharmaceutical Ingredients (API) size is estimated to be xx million in 2021 from USD 69660 million in 2020, with a change of XX% between 2020 and 2021. The global Active Pharmaceutical Ingredients (API) market size is expected to grow at a CAGR of 6.3% for the next five years.
Market segmentation
Active Pharmaceutical Ingredients (API) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Synthetic APIs
Biotech APIs
Market segment by Application can be divided into
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
The key market players for global Active Pharmaceutical Ingredients (API) market are listed below:
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Active Pharmaceutical Ingredients (API) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Active Pharmaceutical Ingredients (API), with price, sales, revenue and global market share of Active Pharmaceutical Ingredients (API) in 2018 and 2019.
Chapter 3, the Active Pharmaceutical Ingredients (API) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Active Pharmaceutical Ingredients (API) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Active Pharmaceutical Ingredients (API) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Active Pharmaceutical Ingredients (API) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Active Pharmaceutical Ingredients (API) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Active Pharmaceutical Ingredients (API) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Synthetic APIs
1.2.3 Biotech APIs
1.3 Market Analysis by Application
1.3.1 Overview: Global Active Pharmaceutical Ingredients (API) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Global Active Pharmaceutical Ingredients (API) Market Size & Forecast
1.4.1 Global Active Pharmaceutical Ingredients (API) Sales in Value (2016-2026))
1.4.2 Global Active Pharmaceutical Ingredients (API) Sales in Volume (2016-2026)
1.4.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2016-2026) & (USD/MT)
1.5 Global Active Pharmaceutical Ingredients (API) Production Capacity Analysis
1.5.1 Global Active Pharmaceutical Ingredients (API) Total Production Capacity (2016-2026)
1.5.2 Global Active Pharmaceutical Ingredients (API) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Active Pharmaceutical Ingredients (API) Market Drivers
1.6.2 Active Pharmaceutical Ingredients (API) Market Restraints
1.6.3 Active Pharmaceutical Ingredients (API) Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Active Pharmaceutical Ingredients (API) Product and Services
2.1.4 Teva Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan Active Pharmaceutical Ingredients (API) Product and Services
2.2.4 Mylan Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 DSM
2.3.1 DSM Details
2.3.2 DSM Major Business
2.3.3 DSM Active Pharmaceutical Ingredients (API) Product and Services
2.3.4 DSM Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Aurobindo Pharma
2.4.1 Aurobindo Pharma Details
2.4.2 Aurobindo Pharma Major Business
2.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product and Services
2.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Aspen
2.5.1 Aspen Details
2.5.2 Aspen Major Business
2.5.3 Aspen Active Pharmaceutical Ingredients (API) Product and Services
2.5.4 Aspen Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Active Pharmaceutical Ingredients (API) Product and Services
2.6.4 Novartis Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 BASF
2.7.1 BASF Details
2.7.2 BASF Major Business
2.7.3 BASF Active Pharmaceutical Ingredients (API) Product and Services
2.7.4 BASF Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Active Pharmaceutical Ingredients (API) Product and Services
2.8.4 Pfizer Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Huahai Pharmaceutical
2.9.1 Huahai Pharmaceutical Details
2.9.2 Huahai Pharmaceutical Major Business
2.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services
2.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Hisun Pharmaceutical
2.10.1 Hisun Pharmaceutical Details
2.10.2 Hisun Pharmaceutical Major Business
2.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services
2.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Sun Pharmaceutical Industries
2.11.1 Sun Pharmaceutical Industries Details
2.11.2 Sun Pharmaceutical Industries Major Business
2.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product and Services
2.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Zhejiang Medicine
2.12.1 Zhejiang Medicine Details
2.12.2 Zhejiang Medicine Major Business
2.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product and Services
2.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Dr. Reddy’s Laboratories
2.13.1 Dr. Reddy’s Laboratories Details
2.13.2 Dr. Reddy’s Laboratories Major Business
2.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product and Services
2.13.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Zhejiang NHU
2.14.1 Zhejiang NHU Details
2.14.2 Zhejiang NHU Major Business
2.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product and Services
2.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Active Pharmaceutical Ingredients (API) Product and Services
2.15.4 Bayer Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 NCPC
2.16.1 NCPC Details
2.16.2 NCPC Major Business
2.16.3 NCPC Active Pharmaceutical Ingredients (API) Product and Services
2.16.4 NCPC Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 AbbVie
2.17.1 AbbVie Details
2.17.2 AbbVie Major Business
2.17.3 AbbVie Active Pharmaceutical Ingredients (API) Product and Services
2.17.4 AbbVie Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Shandong Xinhua Pharmaceutical
2.18.1 Shandong Xinhua Pharmaceutical Details
2.18.2 Shandong Xinhua Pharmaceutical Major Business
2.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services
2.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Northeast Pharm
2.19.1 Northeast Pharm Details
2.19.2 Northeast Pharm Major Business
2.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Product and Services
2.19.4 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Harbin Pharmaceutical
2.20.1 Harbin Pharmaceutical Details
2.20.2 Harbin Pharmaceutical Major Business
2.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services
2.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 LKPC
2.21.1 LKPC Details
2.21.2 LKPC Major Business
2.21.3 LKPC Active Pharmaceutical Ingredients (API) Product and Services
2.21.4 LKPC Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Active Pharmaceutical Ingredients (API) Sales by Manufacturer
3.1 Global Active Pharmaceutical Ingredients (API) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Active Pharmaceutical Ingredients (API)
3.4 Market Concentration Rate
3.4.1 Top 3 Active Pharmaceutical Ingredients (API) Manufacturer Market Share
3.4.2 Top 6 Active Pharmaceutical Ingredients (API) Manufacturer Market Share
3.5 Global Active Pharmaceutical Ingredients (API) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Active Pharmaceutical Ingredients (API) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Active Pharmaceutical Ingredients (API) Market Size by Region
4.1.1 Global Active Pharmaceutical Ingredients (API) Sales in Volume by Region (2016-2026)
4.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2026)
4.2 North America Active Pharmaceutical Ingredients (API) Revenue (2016-2026)
4.3 Europe Active Pharmaceutical Ingredients (API) Revenue (2016-2026)
4.4 Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue (2016-2026)
4.5 South America Active Pharmaceutical Ingredients (API) Revenue (2016-2026)
4.6 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Active Pharmaceutical Ingredients (API) Sales in Volume by Type (2016-2026)
5.2 Global Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2026)
5.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Active Pharmaceutical Ingredients (API) Sales in Volume by Application (2016-2026)
6.2 Global Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2026)
6.3 Global Active Pharmaceutical Ingredients (API) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Active Pharmaceutical Ingredients (API) Sales by Type (2016-2026)
7.2 North America Active Pharmaceutical Ingredients (API) Sales by Application (2016-2026)
7.3 North America Active Pharmaceutical Ingredients (API) Market Size by Country
7.3.1 North America Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2016-2026)
7.3.2 North America Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Active Pharmaceutical Ingredients (API) Sales by Type (2016-2026)
8.2 Europe Active Pharmaceutical Ingredients (API) Sales by Application (2016-2026)
8.3 Europe Active Pharmaceutical Ingredients (API) Market Size by Country
8.3.1 Europe Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2016-2026)
8.3.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2016-2026)
9.2 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2016-2026)
9.3 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size by Region
9.3.1 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Active Pharmaceutical Ingredients (API) Sales by Type (2016-2026)
10.2 South America Active Pharmaceutical Ingredients (API) Sales by Application (2016-2026)
10.3 South America Active Pharmaceutical Ingredients (API) Market Size by Country
10.3.1 South America Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2016-2026)
10.3.2 South America Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Type (2016-2026)
11.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Application (2016-2026)
11.3 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size by Country
11.3.1 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Active Pharmaceutical Ingredients (API) Typical Distributors
12.3 Active Pharmaceutical Ingredients (API) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Active Pharmaceutical Ingredients (API) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Active Pharmaceutical Ingredients (API) Revenue by Application, (USD Million), 2021-2026
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Active Pharmaceutical Ingredients (API) Product and Services
Table 6. Teva Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Mylan Basic Information, Manufacturing Base and Competitors
Table 8. Mylan Major Business
Table 9. Mylan Active Pharmaceutical Ingredients (API) Product and Services
Table 10. Mylan Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. DSM Basic Information, Manufacturing Base and Competitors
Table 12. DSM Major Business
Table 13. DSM Active Pharmaceutical Ingredients (API) Product and Services
Table 14. DSM Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Aurobindo Pharma Major Business
Table 17. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product and Services
Table 18. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Aspen Basic Information, Manufacturing Base and Competitors
Table 20. Aspen Major Business
Table 21. Aspen Active Pharmaceutical Ingredients (API) Product and Services
Table 22. Aspen Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Active Pharmaceutical Ingredients (API) Product and Services
Table 26. Novartis Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. BASF Basic Information, Manufacturing Base and Competitors
Table 28. BASF Major Business
Table 29. BASF Active Pharmaceutical Ingredients (API) Product and Services
Table 30. BASF Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Active Pharmaceutical Ingredients (API) Product and Services
Table 34. Pfizer Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Huahai Pharmaceutical Major Business
Table 37. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services
Table 38. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Hisun Pharmaceutical Major Business
Table 41. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services
Table 42. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharmaceutical Industries Major Business
Table 45. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product and Services
Table 46. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Zhejiang Medicine Basic Information, Manufacturing Base and Competitors
Table 48. Zhejiang Medicine Major Business
Table 49. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product and Services
Table 50. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 52. Dr. Reddy’s Laboratories Major Business
Table 53. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product and Services
Table 54. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Zhejiang NHU Basic Information, Manufacturing Base and Competitors
Table 56. Zhejiang NHU Major Business
Table 57. Zhejiang NHU Active Pharmaceutical Ingredients (API) Product and Services
Table 58. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Bayer Basic Information, Manufacturing Base and Competitors
Table 60. Bayer Major Business
Table 61. Bayer Active Pharmaceutical Ingredients (API) Product and Services
Table 62. Bayer Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. NCPC Basic Information, Manufacturing Base and Competitors
Table 64. NCPC Major Business
Table 65. NCPC Active Pharmaceutical Ingredients (API) Product and Services
Table 66. NCPC Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. AbbVie Basic Information, Manufacturing Base and Competitors
Table 68. AbbVie Major Business
Table 69. AbbVie Active Pharmaceutical Ingredients (API) Product and Services
Table 70. AbbVie Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Shandong Xinhua Pharmaceutical Major Business
Table 73. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services
Table 74. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Northeast Pharm Basic Information, Manufacturing Base and Competitors
Table 76. Northeast Pharm Major Business
Table 77. Northeast Pharm Active Pharmaceutical Ingredients (API) Product and Services
Table 78. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Harbin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Harbin Pharmaceutical Major Business
Table 81. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services
Table 82. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. LKPC Basic Information, Manufacturing Base and Competitors
Table 84. LKPC Major Business
Table 85. LKPC Active Pharmaceutical Ingredients (API) Product and Services
Table 86. LKPC Active Pharmaceutical Ingredients (API) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Global Active Pharmaceutical Ingredients (API) Sales by Manufacturer (2019-2021e) & (K MT)
Table 88. Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 89. Market Position of Manufacturers in Active Pharmaceutical Ingredients (API), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 90. Global Active Pharmaceutical Ingredients (API) Production Capacity by Company, (K MT): 2020 VS 2021
Table 91. Head Office and Active Pharmaceutical Ingredients (API) Production Site of Key Manufacturer
Table 92. Active Pharmaceutical Ingredients (API) New Entrant and Capacity Expansion Plans
Table 93. Active Pharmaceutical Ingredients (API) Mergers & Acquisitions in the Past Five Years
Table 94. Global Active Pharmaceutical Ingredients (API) Sales by Region (2016-2021e) & (K MT)
Table 95. Global Active Pharmaceutical Ingredients (API) Sales by Region (2021-2026) & (K MT)
Table 96. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2021e) & (USD Million)
Table 97. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2021-2026) & (USD Million)
Table 98. Global Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021e) & (K MT)
Table 99. Global Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (K MT)
Table 100. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2021e) & (USD Million)
Table 101. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2026) & (USD Million)
Table 102. Global Active Pharmaceutical Ingredients (API) Price by Type (2016-2021e) & (USD/MT)
Table 103. Global Active Pharmaceutical Ingredients (API) Price by Type (2021-2026) & (USD/MT)
Table 104. Global Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021e) & (K MT)
Table 105. Global Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (K MT)
Table 106. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2021e) & (USD Million)
Table 107. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2026) & (USD Million)
Table 108. Global Active Pharmaceutical Ingredients (API) Price by Application (2016-2021e) & (USD/MT)
Table 109. Global Active Pharmaceutical Ingredients (API) Price by Application (2021-2026) & (USD/MT)
Table 110. North America Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021e) & (K MT)
Table 111. North America Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (K MT)
Table 112. North America Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021e) & (USD Million)
Table 113. North America Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2026) & (USD Million)
Table 114. North America Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021e) & (K MT)
Table 115. North America Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (K MT)
Table 116. North America Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021e) & (K MT)
Table 117. North America Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (K MT)
Table 118. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021e) & (K MT)
Table 119. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (K MT)
Table 120. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021e) & (USD Million)
Table 121. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2026) & (USD Million)
Table 122. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021e) & (K MT)
Table 123. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (K MT)
Table 124. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021e) & (K MT)
Table 125. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (K MT)
Table 126. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2016-2021e) & (K MT)
Table 127. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2021-2026) & (K MT)
Table 128. Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2021e) & (USD Million)
Table 129. Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2021-2026) & (USD Million)
Table 130. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021e) & (K MT)
Table 131. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (K MT)
Table 132. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021e) & (K MT)
Table 133. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (K MT)
Table 134. South America Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021e) & (K MT)
Table 135. South America Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (K MT)
Table 136. South America Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021e) & (USD Million)
Table 137. South America Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2026) & (USD Million)
Table 138. South America Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021e) & (K MT)
Table 139. South America Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (K MT)
Table 140. South America Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021e) & (K MT)
Table 141. South America Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (K MT)
Table 142. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021e) & (K MT)
Table 143. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (K MT)
Table 144. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021e) & (USD Million)
Table 145. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2026) & (USD Million)
Table 146. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021e) & (K MT)
Table 147. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (K MT)
Table 148. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021e) & (K MT)
Table 149. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (K MT)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Active Pharmaceutical Ingredients (API) Typical Distributors
Table 153. Active Pharmaceutical Ingredients (API) Typical Customers
List of Figures
Figure 1. Active Pharmaceutical Ingredients (API) Picture
Figure 2. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 3. Synthetic APIs
Figure 4. Biotech APIs
Figure 5. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020
Figure 6. CNS
Figure 7. Cardiovascular
Figure 8. Genitourinary/Hormonal Drugs
Figure 9. Respiratory
Figure 10. Rheumatology
Figure 11. Diabetes
Figure 12. Oncology
Figure 13. Others
Figure 14. Global Active Pharmaceutical Ingredients (API) Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 15. Global Active Pharmaceutical Ingredients (API) Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Active Pharmaceutical Ingredients (API) Sales (2016-2026) & (K MT)
Figure 17. Global Active Pharmaceutical Ingredients (API) Price by Type (2016-2026) & (USD/MT)
Figure 18. Global Active Pharmaceutical Ingredients (API) Production Capacity (2016-2026) & (K MT)
Figure 19. Global Active Pharmaceutical Ingredients (API) Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Active Pharmaceutical Ingredients (API) Market Drivers
Figure 21. Active Pharmaceutical Ingredients (API) Market Restraints
Figure 22. Active Pharmaceutical Ingredients (API) Market Trends
Figure 23. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturer in 2020
Figure 24. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturer in 2020
Figure 25. Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Active Pharmaceutical Ingredients (API) Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Active Pharmaceutical Ingredients (API) Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2026)
Figure 29. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2026)
Figure 30. North America Active Pharmaceutical Ingredients (API) Revenue (2016-2026) & (USD Million)
Figure 31. Europe Active Pharmaceutical Ingredients (API) Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue (2016-2026) & (USD Million)
Figure 33. South America Active Pharmaceutical Ingredients (API) Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue (2016-2026) & (USD Million)
Figure 35. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2026)
Figure 36. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2016-2026)
Figure 37. Global Active Pharmaceutical Ingredients (API) Price by Type (2016-2026) & (USD/MT)
Figure 38. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2026)
Figure 39. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2016-2026)
Figure 40. Global Active Pharmaceutical Ingredients (API) Price by Application (2016-2026) & (USD/MT)
Figure 41. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2026)
Figure 42. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2026)
Figure 43. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2026)
Figure 44. North America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2026)
Figure 45. United States Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2026)
Figure 49. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2026)
Figure 50. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2026)
Figure 51. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2026)
Figure 52. Germany Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2026)
Figure 61. China Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2026)
Figure 68. South America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2026)
Figure 69. South America Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2026)
Figure 70. South America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
